SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applications of Cardiac Bio-Markers

Apple, FS; Collinson, PO; Kavsak, PA; Body, R; Ordóñez-Llanos, J; Saenger, AK; Omland, T; Hammarsten, O; Jaffe, AS; IFCC Committee Clinical Application of Cardiac Biomarkers (2021) Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applications of Cardiac Bio-Markers. Clin Chem, 67 (5). pp. 730-735. ISSN 1530-8561 https://doi.org/10.1093/clinchem/hvaa337
SGUL Authors: Collinson, Paul

[img]
Preview
PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (103kB) | Preview

Abstract

The Committee on the Clinical Application of Cardiac Biomarkers (C-CB) of the International Federation of Clinical Chemistry (IFCC) represents international groups from laboratory medicine, cardiology and emergency medicine involved in providing global educational guidance pertaining to the analytical and clinical applications of cardiac biomarkers. For that reason, most of the members are involved with national and international studies and trials pertaining to high sensitivity (hs) cardiac troponins I and T (cTnI and cTnT) (1-3). Although the recently published '2020 European Society of Cardiology (ESC) guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation' present some topics very well, the current special report was developed to delineate our specific concerns regarding the ESB guidance for the use of hs-cardiac troponin (hs-cTn) (4).

Item Type: Article
Additional Information: This is a pre-copyedited, author-produced version of an article accepted for publication in Clinical Chemistry following peer review. The version of record Fred S Apple, Paul O Collinson, Peter A Kavsak, Richard Body, Jordi Ordóñez-Llanos, Amy K Saenger, Torbjorn Omland, Ola Hammarsten, Allan S Jaffe, the IFCC Committee on Clinical Applications of Cardiac Bio-Markers, Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applications of Cardiac Bio-Markers, Clinical Chemistry, Volume 67, Issue 5, May 2021, Pages 730–735 is available online at: https://doi.org/10.1093/clinchem/hvaa337
Keywords: IFCC Committee Clinical Application of Cardiac Biomarkers, 1004 Medical Biotechnology, 1101 Medical Biochemistry and Metabolomics, 1103 Clinical Sciences, General Clinical Medicine
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Clin Chem
ISSN: 1530-8561
Language: eng
Dates:
DateEvent
May 2021Published
7 February 2021Published Online
18 December 2020Accepted
Publisher License: Publisher's own licence
PubMed ID: 33377906
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112788
Publisher's version: https://doi.org/10.1093/clinchem/hvaa337

Actions (login required)

Edit Item Edit Item